@article{f93673a8dd8b405eae8210210f07a4d9,
title = "Reporting on circulating tumor DNA monitoring in metastatic cancer-From clinical validity to clinical utility",
abstract = "This commentary attempts to discuss the required standardization of circulating tumor DNA (ctDNA) analyses and thereby improve the clinical validity of ctDNA monitoring in the metastatic setting of solid tumors.",
keywords = "circulating tumor DNA (ctDNA), clinical utility, metastatic cancer, monitoring, reporting on circulating tumor DNA, standardization, Circulating Tumor DNA/genetics, Neoplasms, Second Primary, Humans, Mutation, Neoplasms/genetics, Biomarkers, Tumor/genetics",
author = "{Brenner Thomsen}, Caroline and {Dandanell Juul}, Amanda and Lef{\`e}vre, {Anna Cecilie} and {Glismand Truelsen}, Christina and Edina Dizdarevic and Heidi Ryssel and {Mathilde Kjaer}, Ina and {Lycke Wind}, Karen and Callesen, {Louise Bach} and {Faaborg Larsen}, Louise and {St{\o}chkel Frank}, Malene and {Fredslund Andersen}, Rikke and {Garm Spindler}, Karen-Lise and Anders Jakobsen",
year = "2022",
month = jun,
day = "1",
doi = "10.1002/cncr.34168",
language = "English",
volume = "128",
pages = "2052--2057",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley & Sons Inc.",
number = "11",
}